March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Transcranial Magnetic Stimulation Improves Retinal Function in an Animal Model of Retinal Dystrophy
Author Affiliations & Notes
  • Ygal Rotenstreich
    Goldscheleger Eye Research Institute, Tel Aviv University, Tel Hashomer, Israel
  • Adi Tzameret
    Goldscheleger Eye Research Institute, Tel Aviv University, Tel Hashomer, Israel
  • Avraham Zangen
    Weizmann institute, Rehovot, Israel
  • Footnotes
    Commercial Relationships  Ygal Rotenstreich, None; Adi Tzameret, None; Avraham Zangen, Brainsway.inc (P)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 5562. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ygal Rotenstreich, Adi Tzameret, Avraham Zangen; Transcranial Magnetic Stimulation Improves Retinal Function in an Animal Model of Retinal Dystrophy. Invest. Ophthalmol. Vis. Sci. 2012;53(14):5562.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the effect of transcranial magnetic stimulation (TMS) on retinal function in Royal College of Surgeons (RCS) rats.

Methods: : Four weeks old RCS rats underwent electroretinogram (ERG) before TMS treatment and followed weekly for 7 weeks (11 weeks follow-up). A total of 24 rats received 6 or 12 sessions (1-2 or 1-4 weeks, respectively) of either real (active, n=8 / group) or sham (placebo, n=8 / group) TMS over the right eye. Evaluation of effects was performed using ERG in scotopic and photopic conditions every week in each eye.

Results: : Two weeks of treatment (6 sessions) indicated a delayed and transient improvement in the scotopic maximal negative ERG responses in each eye (24% and 102% of change improvement compared to placebo in the right and left eye respectively, 4 and 5 weeks after treatment p<0.05). Extending the treatment to four weeks (12 sessions) showed greater improvements in the negative ERG responses as well as in the maximal scotopic b-waves ERG amplitude responses. Three to five weeks after treatment the average maximal scotopic b-wave amplitude responses showed significant increase (P<0.05) of up to 637% and 363% of change relative to placebo in the right and left eyes respectively. The single flash photopic b- wave amplitude responses showed increase of 207% and 185% of change compare to placebo in the right and left eyes respectively.

Conclusions: : Using a new application for TMS we showed for the first time that TMS treatment induces delayed improvement of the retinal function in animal model of retinal degeneration. These results suggest that repeated treatment with TMS might induce neural plasticity in the neuroretinal tissue.

Keywords: neuroprotection • plasticity • retinal degenerations: hereditary 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×